Genome-wide analyses of long noncoding RNA expression profiles in lung adenocarcinoma

Area of Science:

• Oncology
• Molecular Biology
• Genomics

Background:

• Long non-coding RNAs (lncRNAs) are increasingly recognized as crucial regulators in various cancers.
• Lung adenocarcinoma (LUAD) pathogenesis involves complex molecular alterations, including dysregulation of non-coding RNAs.

Purpose of the Study:

• To comprehensively map the landscape of lncRNAs and their potential target genes in lung adenocarcinoma.
• To identify specific lncRNAs associated with clinical parameters and patient survival in LUAD.

Main Methods:

• Genome-wide expression profiling of lncRNAs and messenger RNAs (mRNAs) using microarray.
• Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) for validation in tumor and adjacent normal tissues.
• Bioinformatic analysis, including 'cis' and 'trans' co-regulation models and The Cancer Genome Atlas (TCGA) database interrogation.

Main Results:

• A total of 3045 differentially expressed lncRNAs were identified between LUAD tissues and normal adjacent tissues (1048 upregulated, 1997 downregulated).
• The lncRNA NONHSAT077036 expression correlated significantly with N classification and clinical stage.
• Analysis revealed that lower POU2F2 and higher TRIM28 expression were associated with shorter overall survival in LUAD patients.

Conclusions:

• The characterized lncRNA landscape provides novel insights into LUAD biology and pathogenesis.
• Specific lncRNAs and transcription factors (POU2F2, TRIM28) show potential as prognostic biomarkers for lung adenocarcinoma.
• Further investigation of lncRNA-gene regulatory networks may uncover therapeutic targets for LUAD.